Schmallenbergウイルス治療の世界市場

Schmallenbergウイルス治療の世界市場は2030年までに1億5,770万米ドルに達する見込み

2024年に1億940万米ドルと推定されるSchmallenbergウイルス治療の世界市場は、2024年から2030年にかけてCAGR 6.3％で成長し、2030年には1億5,770万米ドルに達すると予測されます。本レポートで分析されているセグメントの一つである牛は、CAGR 5.0％を記録し、分析期間終了時には7,530万米ドルに達すると予測されています。羊セグメントの成長率は、分析期間でCAGR 8.2％と推定されます。

米国市場は2,980万米ドルと推定される一方、中国はCAGR 9.7％で成長予測

米国のSchmallenbergウイルス治療市場は、2024年に2,980万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 9.7%で推移し、2030年には予測市場規模3,200万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.2%と6.1%と予測されています。欧州では、ドイツがCAGR 4.1%で成長すると予測されています。

世界のSchmallenbergウイルス治療市場- 主要動向と促進要因まとめ

シュマレンベルグ・ウイルスの静かな脅威に獣医療セクターはどう取り組んでいるか？

2011年に欧州で初めて確認されたシュマレンベルグ・ウイルス（SBV）は、主にウシ、ヒツジ、ヤギなどの反芻動物に感染し、発熱、乳量減少、流産、先天奇形を引き起こす新興感染症です。この伝染病の蔓延は、主に刺咬性コナジラミ（課題）を媒介とするものであるが、特異的な抗ウイルス治療薬がないため、獣医保健システムにとって難題となっています。現在の市場開拓の焦点は、ワクチンの開発と早期封じ込めのための診断プロトコルの強化の2つです。動物用製薬会社は、より広範で持続性のある免疫を提供できる不活化ワクチンや組み換えワクチンの研究開発を強化しています。欧州、アジア、南米各地の政府および獣医療機関は、地域的なSBV監視プログラム、バイオセキュリティ意識向上、規制上の優遇措置によるワクチン試験の迅速化などの取り組みに資金を提供しています。市場の拡大は、商業耕作地帯における家畜保護の需要増加も後押ししています。

診断の進歩はウイルスの変異を上回っているか？

検出と診断は、シュマレンベルグのアウトブレイクを管理する上で極めて重要な柱となっています。新世代のPCRベースの検査、血清学的 ELISA、ポイントオブケア診断が開発され、生きた動物と胎児の両方で検出精度が向上しています。携帯型の分子検査キットは、特に新興経済諸国において、繁殖期や分娩期の前に病気を特定するため、地方の動物病院での需要が高まっています。天候、ハジラミの移動、家畜の移動に基づくAIを活用した発生予測モデルも、獣医学の意思決定支援システムに統合されつつあります。これらの技術は、非流行地域におけるウイルスの予測不能な再流行を緩和し、酪農・食肉生産における経済的損失を削減するのに役立っています。

バイオセキュリティ政策と世界な家畜貿易が果たす役割とは？

家畜貿易の世界化と気候による媒介動物の拡大は、国境を越えたSBV伝播のリスクを高める極めて重要な要因です。そのため、疾病対策に関する各国間の連携がますます重要になってきています。輸出規制では、SBVに感染していないことが証明された牛群を求める傾向が強まっており、農場は予防接種や予防診断への投資を余儀なくされています。罹患地域の政府や農務省は、家畜の追跡システムやバイオセキュリティのゾーニングを義務化し、疾病の蔓延を防いでいます。さらに、人獣共通感染症や新興感染症に対するパンデミック時代のスポットライトが、獣医療インフラに対する認識と資金を高め、SBV治療市場に間接的な利益をもたらしています。牛群保険会社やアグリビジネスの利害関係者も、責任を最小限に抑えるためにワクチンの採用を推進しています。

Schmallenbergウイルス治療市場の成長はいくつかの要因によって促進される

ワクチンや高感度診断キットなどの予防対策が重視される中、決定的な治療法がないことが市場の成長を後押ししています。特に欧州とラテンアメリカでは、商業的畜産が拡大し、家畜の病気に対する経済的負担が大きくなっているため、効果的なSBV対策への需要が高まっています。動物用ワクチン開発に対する規制当局の支援と迅速な承認が、バイオテクノロジー企業によるSBVに特化した研究開発への投資を後押ししています。気候パターンの変化によって、この病気の地理的範囲が拡大し、治療と防除のための新たな市場が生まれています。統合家畜管理プラットフォームの台頭、獣医療予算の増加、デジタル疾病モニタリングシステムにより、Schmallenbergウイルス治療ソリューションの緊急性と商業的実行可能性が総体的に強化されています。

セグメント

動物タイプ（牛、羊、ヤギ、その他の動物タイプ）;治療タイプ（抗ウイルス薬、抗炎症薬、鎮痛薬、ワクチン）;エンドユーザー（動物病院＆クリニック、調査機関、動物薬局＆ドラッグストア、その他のエンドユーザー）

調査対象企業の例（全36件）

• Bayer Animal Health
• Boehringer Ingelheim
• Ceva Sante Animale
• Dechra Pharmaceuticals
• Elanco Animal Health
• Heska Corporation
• Huvepharma
• IDEXX Laboratories
• IDT Biologika
• Merial（now part of Boehringer Ingelheim）
• MSD Animal Health（Merck Animal Health）
• Neogen Corporation
• Phibro Animal Health
• Vetoquinol
• Virbac
• Zoetis

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Schmallenberg Virus Treatment Market to Reach US$157.7 Million by 2030

The global market for Schmallenberg Virus Treatment estimated at US$109.4 Million in the year 2024, is expected to reach US$157.7 Million by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Cattle, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$75.3 Million by the end of the analysis period. Growth in the Sheep segment is estimated at 8.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$29.8 Million While China is Forecast to Grow at 9.7% CAGR

The Schmallenberg Virus Treatment market in the U.S. is estimated at US$29.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$32.0 Million by the year 2030 trailing a CAGR of 9.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Schmallenberg Virus Treatment Market - Key Trends & Drivers Summarized

How Is the Veterinary Sector Tackling the Silent Threat of Schmallenberg Virus?

First identified in Europe in 2011, Schmallenberg virus (SBV) is an emerging infectious disease that primarily affects ruminants-such as cattle, sheep, and goats-causing fever, reduced milk yield, abortions, and congenital deformities. While its spread is largely vector-borne via biting midges (Culicoides spp.), the lack of specific antiviral treatments has posed a challenge to veterinary health systems. The current focus in the market is twofold: developing vaccines and enhancing diagnostic protocols for early containment. Veterinary pharmaceutical firms are intensifying R&D on inactivated and recombinant vaccines that can provide broader and longer-lasting immunity. Governments and veterinary bodies across Europe, Asia, and South America are funding initiatives for regional SBV surveillance programs, biosecurity awareness, and fast-tracking vaccine trials through regulatory incentives. The market’s expansion is also aided by increasing demand for livestock protection in commercial farming zones.

Are Diagnostic Advancements Outpacing Viral Mutations?

Detection and diagnostics have emerged as crucial pillars in managing Schmallenberg outbreaks. New-generation PCR-based tests, serological ELISAs, and point-of-care diagnostics are being developed to improve detection accuracy in both live animals and fetuses. Portable molecular testing kits are seeing demand in rural veterinary clinics, especially in developing economies, to identify the disease before breeding or calving seasons. AI-powered outbreak prediction models based on weather, midge migration, and livestock movement are also being integrated into veterinary decision-support systems. These technologies are helping mitigate the unpredictable re-emergence of the virus in non-endemic areas, thus reducing economic losses in dairy and meat production.

What Role Do Biosecurity Policies and Global Livestock Trade Play?

The globalization of livestock trade and climate-driven vector expansion are pivotal factors increasing the risk of SBV transmission across borders. As such, cross-country coordination on disease control is becoming more vital. Export regulations now increasingly demand certified SBV-free herds, driving farms to invest in immunization and preventive diagnostics. Governments and agricultural ministries in affected regions have rolled out mandatory livestock tracking systems and biosecurity zoning to limit disease spread. Furthermore, the pandemic-era spotlight on zoonotic and emerging diseases has heightened awareness and funding for veterinary health infrastructure, indirectly benefiting the SBV treatment market. Herd insurance firms and agribusiness stakeholders are also pushing for vaccine adoption to minimize liability.

The Growth in the Schmallenberg Virus Treatment Market Is Driven by Several Factors

The market growth is propelled by the absence of a definitive cure, which emphasizes preventive measures such as vaccines and high-sensitivity diagnostic kits. Expansion of commercial livestock farming, especially in Europe and Latin America, has raised the financial stakes of livestock diseases, increasing demand for effective SBV countermeasures. Regulatory support for veterinary vaccine development and fast-track approvals are encouraging biotech companies to invest in SBV-specific R&D. Changing climate patterns are expanding the geographic range of the disease, creating new markets for treatment and control. The rise of integrated livestock management platforms, increased veterinary healthcare budgets, and digital disease monitoring systems are collectively reinforcing the urgency and commercial viability of Schmallenberg virus treatment solutions.

SCOPE OF STUDY:

The report analyzes the Schmallenberg Virus Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Animal Type (Cattle, Sheep, Goats, Other Animal Types); Treatment Type (Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics, Vaccines); End-Use (Veterinary Hospitals & Clinics, Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Bayer Animal Health
• Boehringer Ingelheim
• Ceva Sante Animale
• Dechra Pharmaceuticals
• Elanco Animal Health
• Heska Corporation
• Huvepharma
• IDEXX Laboratories
• IDT Biologika
• Merial (now part of Boehringer Ingelheim)
• MSD Animal Health (Merck Animal Health)
• Neogen Corporation
• Phibro Animal Health
• Vetoquinol
• Virbac
• Zoetis

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Schmallenberg Virus Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Schmallenberg Virus in Cattle and Sheep Drives Urgency for Therapeutic Development
  • Expansion of Livestock Disease Surveillance Programs Supports Early Detection and Response
  • Government Funding for Zoonotic Disease Research Accelerates Vaccine and Antiviral R&D
  • Growing Veterinary Awareness and Diagnostic Capabilities Strengthen Case for Targeted Treatments
  • Public Concern Over Animal Welfare and Agricultural Losses Spurs Market for Preventive Therapies
  • Academic and Industry Collaborations Enhance Virology Research and Treatment Innovation
  • Lack of Approved Therapeutics Presents White Space for Vaccine Developers and Biopharma Entrants
  • Integration of Schmallenberg Monitoring Into Broader Animal Health Platforms Improves Epidemiological Control
  • Import Restrictions and Trade Concerns Create Economic Incentives for Eradication Programs
  • Barriers in Funding, Commercial Viability, and Regulatory Pathways Challenge Treatment Launch Timelines
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Schmallenberg Virus Treatment Market Analysis of Annual Sales in US$ for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Schmallenberg Virus Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Schmallenberg Virus Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Cattle by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Cattle by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Cattle by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Sheep by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Sheep by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Sheep by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Goats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Goats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Goats by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other Animal Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Research Institutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Veterinary Pharmacies & Drug Store by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Veterinary Pharmacies & Drug Store by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Veterinary Pharmacies & Drug Store by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Veterinary Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Veterinary Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Veterinary Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Antiviral Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Antiviral Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Antiviral Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Anti-Inflammatory Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Analgesics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Analgesics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Analgesics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• JAPAN
  • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• CHINA
  • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• EUROPE
  • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Schmallenberg Virus Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Schmallenberg Virus Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• FRANCE
  • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• GERMANY
  • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Schmallenberg Virus Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Schmallenberg Virus Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• INDIA
  • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Schmallenberg Virus Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Schmallenberg Virus Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Schmallenberg Virus Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Schmallenberg Virus Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030
• AFRICA
  • Schmallenberg Virus Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Schmallenberg Virus Treatment by Animal Type - Cattle, Sheep, Goats and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Schmallenberg Virus Treatment by Animal Type - Percentage Breakdown of Value Sales for Cattle, Sheep, Goats and Other Animal Types for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Schmallenberg Virus Treatment by End-Use - Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Schmallenberg Virus Treatment by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Veterinary Pharmacies & Drug Store, Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Schmallenberg Virus Treatment by Treatment Type - Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Schmallenberg Virus Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antiviral Drugs, Anti-Inflammatory Drugs, Analgesics and Vaccines for the Years 2015, 2025 & 2030

IV. COMPETITION